Pelican Cancer Foundation logo
Donate Now
Pelican Cancer Foundation logo
Search
  • Home
  • About us
    • About us
    • What we do
      • Our achievements
      • The Future
    • Who we are
      • Trustees
      • Our Team
      • Patrons
      • Annual Accounts
    • Partnerships
    • Vacancies
    • News
  • Education
    • Current Courses
      • OReCO
        • OReCO Videos
        • OReCO Partners & Sponsors
        • Pelican OReCO Workshops
      • LARS
      • NETS
      • Bowel Cancer Screening
    • Completed Courses
      • Pelican IMPACT
        • IMPACT – Completion & Evaluation
        • Workshops
        • IMPACT – Online resources
        • IMPACT – Partners and Sponsors
      • SPECC
        • SPECC – Completion & Evaluation
        • Workshops
        • SPECC – Online resources
        • SPECC – Partners and Sponsors
      • LOREC
      • TIPTOP
        • Workshops
        • TIPTOP – Online resources
        • Bob’s story (prostate cancer)
        • Andrew’s story (prostate cancer)
        • Alan’s story (prostate cancer)
        • Raymond’s story (prostate cancer)
    • Films
      • Surgical videos
    • Book a Course
    • Sponsorship
  • Research
    • Current Research
    • Completed Research
      • Bowel cancer research
        • POLARS
        • MERCURY 2 (Low Rectal Cancer Study)
        • Deferral of surgery study
        • TATME
        • IMPRESS
        • TRIGGER
        • Papers of interest
        • Timing of surgery
        • AMSOEC
        • MINSTREL
        • Completed research
          • Perineal wound healing registry
          • Beyond TME
          • Validation of the LARS score
          • MARVEL: Evaluation of EMVI positive rectal cancer
          • FLEX
          • TME Physical Simulation Model
          • Total Mesorectal Excision (TME)
          • MERCURY research programme
      • Liver cancer research
        • Completed research
          • EORTC studies
        • SERENADE
        • Papers of interest
      • Peritoneal malignancy research
        • Colorectal Peritoneal Malignancy Database
        • Pseudomyxoma Pathology Atlas
      • Previous Research Areas
        • Prostate Cancer Research
          • Prostate cancer
          • Focal therapy and HIFU research
          • MRI research for prostate cancer
          • Prostate cancer colloquiums
          • FORECAST
          • Trachtomap
          • Papers of interest
        • Bladder cancer research
          • Bladder cancer
          • Papers of interest
    • Information for research applicants
      • Peer Review Panel Terms of Reference
      • Research Review Panel
      • Research Grant Application Guidance Notes
      • Terms and conditions of grants
      • Animals in medical research
      • Research costs
    • Clinical trials
  • For Patients
    • Patient stories
      • Anthony’s story (bowel cancer)
      • Elena’s story (bowel cancer)
      • Terry’s story (liver cancer)
      • Derrick’s story (liver cancer)
      • Alex’s story (colorectal cancer)
      • Cheryll’s story (rectal cancer)
      • Eileen’s story
      • Richard’s story – irrigation
      • Tom’s story – complete response
      • Advanced metastatic bowel cancer
    • What is an MDT?
      • What an MRI reveals
      • Reporting cancer outcomes
    • Bowel cancer
      • Our bowel cancer team
      • About bowel cancer treatment – TME
      • April – Bowel Cancer Awareness Month
      • Low rectal cancer
      • Complete response to chemoradiotherapy in rectal cancer
      • Frequently asked questions about bowel cancer
      • Irrigation for colostomies
      • A patient’s advice
      • Symptom checker
      • Bowel cancer – useful contacts
    • Liver cancer
      • Our liver cancer team
      • About liver cancer treatment
      • Interventional radiology
      • Liver cancer – frequently asked questions
      • Carcinoid and neuroendocrine tumours
      • Liver cancer – want to read more?
    • Pseudomyxoma peritonei
    • Getting a second opinion
    • Clinical trials
      • Current clinical trials
    • Tell us your story
    • Still got questions about cancer?
    • Links
  • Support us
    • Make a donation
      • Make a donation
      • Shares
      • In memory
    • Fundraise for us
      • Our fundraisers
      • Fundraising ideas
      • Fundraising challenges
      • Fundraising resources
    • Leave a Gift in your Will
    • Become a Corporate Partner
    • Trusts, Foundations & Philanthropy
    • Tell us your story
  • Contact us

AMSOEC

AMSOEC - Avoiding major surgical operations in early colorectal cancer 

Dr Scarlet Brockmoeller

NIHR Academic Clinical Lecturer

University of Leeds

scarlet

Since the NHS started screening for bowel cancer, the number of cases where colorectal cancer is detected at an early stage (when the tumour is small and has not spread) has tripled, reaching 17%. Many patients with early cancers can be treated successfully without the need for a major operation (i.e. the cancer can just be cut out with a limited procedure inside the bowel rather than removing the whole segment of bowel containing the tumour). With this approach, there is concern that cancer could be left behind if it has spread to the lymph nodes (or glands) around the bowel, so doctors need to predict which patients are at risk of lymph node spread before deciding on the best treatment approach.

This study looked at data from 207 patients with early colorectal cancer and the researchers used statistical tests to analyse the data and created a model to predict if cancer might have spread to the lymph nodes. They found that certain factors were linked to cancer spread, including the appearance of the tumour's surrounding tissue, how far the cancer had spread into the tissue underneath, how well the tumour cells were differentiated, and if there was evidence of lymphatic invasion (spread into channels leading to lymph nodes). This model identified 90-95% of patients where cancer had spread to the lymph nodes, and suggested surgery for about 34% to 35% of the patients. Using this model could therefore potentially predict the 65-66% of patients who could safely avoid a major operation. Although these results are encouraging, this approach needs to be tested further before it can be used widely.

Pelican supported this study with a grant of £20,000.

Keep in touch

We love to email you about our latest news, campaigns, research and ways you can support us

Sign Up

You can find out more about your rights, how we use your personal information and how
we keep your details safe and secure by reading our Privacy Policy.

© 2025 Pelican Cancer Foundation. All Rights Reserved. Registered Charity Number: 1141911 - Privacy Policy